The global peritoneal dialysis market was valued at USD 3,589.9 Million in 2017 and is projected to reach USD 6,077.2 Million by 2025, exhibiting a CAGR of 6.9% As stated in the report, in 2017 the Asia Pacific market was valued at US$ 1194.1 Mn. The region is also anticipated to hold a significant share in the global market during the forecast period 2018-2025. The Asia Pacific market is driven by the high prevalence of chronic kidney disease in the region.
Moreover, liberal reimbursement policies and increasing government support for healthcare services in the region is likely to contribute to the Asia Pacific peritoneal dialysis market expansion. India and China are some of the fastest growing economies in the world and are attracting a lot of investments. Baxter (a leading player in the healthcare industry) is expanding its operations in China and India. This in response is likely to propel growth the global market.
North America also held a significant share in the global market in 2017. However, the region may grow at a relatively slower CAGR during the forecast period. The growth witnessed is attributable to the smaller patient pool in the region compared to Asia Pacific and other regions.
Get Sample PDF Brochure@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/peritoneal-dialysis-market-100089
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Baxter International Inc.
• Fresenius Kabi AG
• Utah Medical Products, Inc.
• Glomeria Therapeutics
• Poly Medicure Ltd.
• Cook Medical Inc.
• CardioMed Supplies, Inc.
• Medical Components, Inc.
“Baxter Expanding its Operations in India and China”
Baxter, is leading the peritoneal dialysis market at present and is anticipated to dominate the global market during the forecast period as well. The growth witnessed is attributable to company’s diverse product portfolio and strong brand presence across the global. This is likely to increase the competition and propel growth in the market.
Some of the companies operating in the Peritoneal Dialysis Market are Baxter International Inc., Fresenius Kabi AG, Medtronic, Utah Medical Products Inc., Glomeria Therapeutics, Poly Medicure Ltd., Cook Medical Inc., CardioMed Supplies Inc., and Medical Components Inc.
Order Full Report@ https://www.fortunebusinessinsights.com/checkout-page/100089
“Automated Peritoneal Dialysis Stood Out as Most Preferred Treatment”
In terms of type, the continuous ambulatory peritoneal dialysis (CAPD) segment emerged dominant in the Peritoneal Dialysis Market in 2017. The segment accounted for 53% of the global market in the given year. However, the automated peritoneal dialysis (APD) segment is anticipated to expand at a relatively higher CAGR. The growth witnessed is attributable to increasing patients preferring to choose APD, backed by recent technological advancements in the segment. This is expected to fuel the demand for peritoneal dialysis solutions.
According to an article published by the National Centre for Biotechnology Information in 2015. In the U.S. among the patients undergoing peritoneal dialysis 60% choose APD, and in Europe, only 50% patients choose APD. The adoption of automated peritoneal dialysis is increasing and is likely to increase the growth rate in the global market.
The global market will gain significant impetus from the rising awareness about the advantages that peritoneal dialysis offers such as flexible treatment and reduced hospital visits. On the contrary high cost and complications associated with peritoneal dialysis machine and equipment is a major factor that may hamper the growth in the Peritoneal Dialysis Market.
Peritoneal Dialysis Market Segmentation:
• Home health care
• Hospitals and Others
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Table of Content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities & Trends
4. Key Insights
4.1. Global Prevalence of CKD (2016)
4.2. Global Prevalence of treated End-stage Renal Disease (2016)
4.3. Estimated Number of Patients on HD vs PD (2017)
4.4. Overview of Major Dialysis Services Providers
4.5. Number of Nephrologists (2016)
4.6. Number of Nephrologists by Continent (2016)
More Trending Topics from Future Business Insights-
Global Genomics Market Size, Share, Industry Analysis, Trends, Demand, Growth Opportunity, Regional Outlook, & Forecast 2018-2026
Surgical Robots Market to Reach US$ 6,875.1 Mn by 2026 Driven by Increasing Regulatory Approvals